These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
For the quarterly period ended March 31, 2017
|
|
|
OR
|
|
|
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For transition period from to
|
|
|
Commission File Number 001-36773
|
|
|
Delaware
(State or other jurisdiction of incorporation or organization)
|
|
47-2509828
(I.R.S. Employer Identification Number)
|
|
|
2900 University Blvd
Ames, IA 50010
(888) 275-3125
|
|||
|
(Address of principal executive offices and zip code)
|
|||
|
(888) 275-3125
|
|||
|
(Registrant's telephone number, including area code)
|
|||
|
___________________________________
|
|||
|
Large accelerated filer
o
|
Accelerated filer
ý
|
|
|
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
|
|
|
Emerging growth company
ý
|
|
|
|
|
Page
|
|
|
|
|
|
|
Item 1
.
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
|
|||
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|
||
|
|
|
||
|
WORKIVA INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
|
|||||||
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
||||
|
|
(unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
Marketable securities
|
|
|
|
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $1,186 and $900 at March 31, 2017 and December 31, 2016, respectively
|
|
|
|
|
|
||
|
Deferred commissions
|
|
|
|
|
|
||
|
Other receivables
|
|
|
|
|
|
||
|
Prepaid expenses
|
|
|
|
|
|
||
|
Total current assets
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Property and equipment, net
|
|
|
|
|
|
||
|
Intangible assets, net
|
|
|
|
|
|
||
|
Other assets
|
|
|
|
|
|
||
|
Total assets
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|||||||
|
Current liabilities
|
|
|
|
||||
|
Accounts payable
|
$
|
|
|
|
$
|
|
|
|
Accrued expenses and other current liabilities
|
|
|
|
|
|
||
|
Deferred revenue
|
|
|
|
|
|
||
|
Deferred government grant obligation
|
|
|
|
|
|
||
|
Current portion of capital lease and financing obligations
|
|
|
|
|
|
||
|
Current portion of long-term debt
|
|
|
|
|
|
||
|
Total current liabilities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Deferred revenue
|
|
|
|
|
|
||
|
Deferred government grant obligation
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
|
|
|
|
||
|
Capital lease and financing obligations
|
|
|
|
|
|
||
|
Long-term debt
|
|
|
|
|
|
||
|
Total liabilities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Stockholders’ deficit
|
|
|
|
||||
|
Class A common stock, $0.001 par value per share, 1,000,000,000 shares authorized, 30,449,500 and 30,369,199 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively
|
|
|
|
|
|
||
|
Class B common stock, $0.001 par value per share, 500,000,000 shares authorized, 10,867,888 and 10,891,888 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively
|
|
|
|
|
|
||
|
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding
|
|
|
|
|
|
||
|
Additional paid-in-capital
|
|
|
|
|
|
||
|
Accumulated deficit
|
(
|
)
|
|
(
|
)
|
||
|
Accumulated other comprehensive income
|
|
|
|
|
|
||
|
Total stockholders’ deficit
|
(
|
)
|
|
(
|
)
|
||
|
Total liabilities and stockholders’ deficit
|
$
|
|
|
|
$
|
|
|
|
WORKIVA INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(unaudited)
|
|||||||
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Revenue
|
|
|
|
||||
|
Subscription and support
|
$
|
|
|
|
$
|
|
|
|
Professional services
|
|
|
|
|
|
||
|
Total revenue
|
|
|
|
|
|
||
|
Cost of revenue
|
|
|
|
||||
|
Subscription and support
|
|
|
|
|
|
||
|
Professional services
|
|
|
|
|
|
||
|
Total cost of revenue
|
|
|
|
|
|
||
|
Gross profit
|
|
|
|
|
|
||
|
Operating expenses
|
|
|
|
||||
|
Research and development
|
|
|
|
|
|
||
|
Sales and marketing
|
|
|
|
|
|
||
|
General and administrative
|
|
|
|
|
|
||
|
Total operating expenses
|
|
|
|
|
|
||
|
Loss from operations
|
(
|
)
|
|
(
|
)
|
||
|
Interest expense
|
(
|
)
|
|
(
|
)
|
||
|
Other income, net
|
|
|
|
|
|
||
|
Loss before provision for income taxes
|
(
|
)
|
|
(
|
)
|
||
|
Provision for income taxes
|
|
|
|
|
|
||
|
Net loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Net loss per common share:
|
|
|
|
||||
|
Basic and diluted
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Weighted-average common shares outstanding - basic and diluted
|
|
|
|
|
|
||
|
WORKIVA INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands)
(unaudited)
|
|||||||
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Net loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Other comprehensive loss, net of tax
|
|
|
|
||||
|
Foreign currency translation adjustment, net of income tax benefit (expense) of $2 and $0 for the three months ended March 31, 2017 and 2016, respectively
|
(
|
)
|
|
(
|
)
|
||
|
Unrealized gain on available-for-sale securities, net of income tax (expense) benefit of ($2) and $0 for the three months ended March 31, 2017 and 2016, respectively
|
|
|
|
|
|
||
|
Other comprehensive loss, net of tax
|
(
|
)
|
|
(
|
)
|
||
|
Comprehensive loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
WORKIVA INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
|
|||||||
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cash flows from operating activities
|
|
|
|
||||
|
Net loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
|
|
|
|
||||
|
Depreciation and amortization
|
|
|
|
|
|
||
|
Stock-based compensation expense
|
|
|
|
|
|
||
|
Provision for doubtful accounts
|
|
|
|
|
|
||
|
Realized gain on sale of available-for-sale securities, net
|
|
|
|
(
|
)
|
||
|
Amortization of premiums and discounts on marketable securities, net
|
|
|
|
|
|
||
|
Recognition of deferred government grant obligation
|
(
|
)
|
|
(
|
)
|
||
|
Changes in assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
|
|
|
(
|
)
|
||
|
Deferred commissions
|
(
|
)
|
|
(
|
)
|
||
|
Other receivables
|
|
|
|
(
|
)
|
||
|
Prepaid expenses and other
|
|
|
|
(
|
)
|
||
|
Other assets
|
(
|
)
|
|
(
|
)
|
||
|
Accounts payable
|
|
|
|
(
|
)
|
||
|
Deferred revenue
|
|
|
|
(
|
)
|
||
|
Accrued expenses and other liabilities
|
(
|
)
|
|
(
|
)
|
||
|
Net cash provided by (used in) operating activities
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Cash flows from investing activities
|
|
|
|
||||
|
Purchase of property and equipment
|
(
|
)
|
|
(
|
)
|
||
|
Purchase of marketable securities
|
(
|
)
|
|
|
|
||
|
Maturities of marketable securities
|
|
|
|
|
|
||
|
Sale of marketable securities
|
|
|
|
|
|
||
|
Purchase of intangible assets
|
(
|
)
|
|
(
|
)
|
||
|
Net cash (used in) provided by investing activities
|
(
|
)
|
|
|
|
||
|
|
|
|
|
||||
|
Cash flows from financing activities
|
|
|
|
||||
|
Proceeds from option exercises
|
|
|
|
|
|
||
|
Taxes paid related to net share settlements of stock-based compensation awards
|
(
|
)
|
|
(
|
)
|
||
|
Principal payments on capital lease and financing obligations
|
(
|
)
|
|
(
|
)
|
||
|
Proceeds from government grants
|
|
|
|
|
|
||
|
Net cash used in financing activities
|
(
|
)
|
|
(
|
)
|
||
|
Effect of foreign exchange rates on cash
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Net increase (decrease) in cash and cash equivalents
|
|
|
|
(
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Supplemental cash flow disclosure
|
|
|
|
||||
|
Cash paid for interest
|
$
|
|
|
|
$
|
|
|
|
Cash paid for income taxes, net of refunds
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Supplemental disclosure of noncash investing and financing activities
|
|
|
|
||||
|
Allowance for tenant improvements
|
$
|
|
|
|
$
|
|
|
|
Purchases of property and equipment, accrued but not paid
|
$
|
|
|
|
$
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Accrued vacation
|
$
|
|
|
|
$
|
|
|
|
Accrued commissions
|
|
|
|
|
|
||
|
Accrued bonuses
|
|
|
|
|
|
||
|
Estimated health insurance claims
|
|
|
|
|
|
||
|
Accrued other liabilities
|
|
|
|
|
|
||
|
|
$
|
|
|
|
$
|
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Interest income
|
$
|
|
|
|
$
|
|
|
|
Income from training reimbursement program
|
|
|
|
|
|
||
|
Other
|
(
|
)
|
|
|
|
||
|
|
$
|
|
|
|
$
|
|
|
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Aggregate Fair Value
|
||||||||
|
U.S. treasury debt securities
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
U.S. corporate debt securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Money market funds
|
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Included in cash and cash equivalents
|
$
|
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
|
|
|
Included in marketable securities
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Aggregate Fair Value
|
||||||||
|
U.S. treasury debt securities
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
U.S. corporate debt securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Money market funds
|
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Included in cash and cash equivalents
|
$
|
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
|
|
|
Included in marketable securities
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
As of March 31, 2017
|
||||||||||||||
|
|
Less than 12 months
|
|
12 months or greater
|
||||||||||||
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
||||||||
|
U.S. treasury debt securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
U.S. corporate debt securities
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||
|
Total
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Level 1 -
|
Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
|
|
Level 2 -
|
Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.
|
|
Level 3 -
|
Inputs are unobservable inputs based on our assumptions.
|
|
|
|
Fair Value Measurements as of March 31, 2017
|
|
Fair Value Measurements as of December 31, 2016
|
||||||||||||||||||||
|
Description
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
||||||||||||
|
Money market funds
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
U.S. treasury debt securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
U.S. corporate debt securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Included in cash and cash equivalents
|
|
$
|
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
||||||||
|
Included in marketable securities
|
|
$
|
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
||||||||
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cost of revenue
|
|
|
|
||||
|
Subscription and support
|
$
|
|
|
|
$
|
|
|
|
Professional services
|
|
|
|
|
|
||
|
Operating expenses
|
|
|
|
||||
|
Research and development
|
|
|
|
|
|
||
|
Sales and marketing
|
|
|
|
|
|
||
|
General and administrative
|
|
|
|
|
|
||
|
Total
|
$
|
|
|
|
$
|
|
|
|
|
Three months ended March 31,
|
||
|
|
2017
|
|
2016
|
|
Expected term (in years)
|
6.0 - 6.1
|
|
6.0 - 6.1
|
|
Risk-free interest rate
|
2.09% - 2.14%
|
|
1.48% - 1.90%
|
|
Expected volatility
|
39.9% - 43.8%
|
|
45.0% - 45.3%
|
|
|
Options
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term (Years)
|
|
Aggregate Intrinsic Value
|
|||||
|
|
|
|
|
|
|
|
(in thousands)
|
|||||
|
Outstanding at December 31, 2016
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
|||
|
Forfeited
|
(
|
)
|
|
|
|
|
|
|
|
|||
|
Exercised
|
(
|
)
|
|
|
|
|
|
|
|
|||
|
Outstanding at March 31, 2017
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Exercisable at March 31, 2017
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
Number of Shares
|
|
Weighted-
Average Grant Date Fair Value |
|||
|
|
|
|
|
|||
|
Unvested at December 31, 2016
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
Vested
|
(
|
)
|
|
|
|
|
|
Unvested at March 31, 2017
|
|
|
|
$
|
|
|
|
|
Number of Shares
|
|
Weighted-
Average Grant Date Fair Value |
|||
|
|
|
|
|
|||
|
Unvested at December 31, 2016
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
Vested
(1)
|
(
|
)
|
|
|
|
|
|
Unvested at March 31, 2017
|
|
|
|
$
|
|
|
|
|
Three months ended
|
||||||||||||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||||||||||||
|
|
Class A
|
|
Class B
|
|
Class A
|
|
Class B
|
||||||||
|
Numerator
|
|
|
|
|
|
|
|
||||||||
|
Net loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator
|
|
|
|
|
|
|
|
||||||||
|
Weighted-average common shares outstanding - basic and diluted
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic and diluted net loss per share
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||
|
Shares subject to outstanding common stock options
|
|
|
|
|
|
|
Shares subject to unvested restricted stock awards
|
|
|
|
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(dollars in thousands)
|
||||||
|
Financial metrics
|
|
|
|
||||
|
Total revenue
|
$
|
51,904
|
|
|
$
|
44,551
|
|
|
Percentage increase in total revenue
|
16.5
|
%
|
|
26.7
|
%
|
||
|
Subscription and support revenue
|
$
|
39,540
|
|
|
$
|
33,585
|
|
|
Percentage increase in subscription and support revenue
|
17.7
|
%
|
|
27.9
|
%
|
||
|
Subscription and support as a percent of total revenue
|
76.2
|
%
|
|
75.4
|
%
|
||
|
|
As of March 31,
|
||
|
|
2017
|
|
2016
|
|
Operating metrics
|
|
|
|
|
Number of customers
|
2,825
|
|
2,557
|
|
Subscription and support revenue retention rate
|
95.1%
|
|
96.1%
|
|
Subscription and support revenue retention rate including add-ons
|
106.6%
|
|
112.1%
|
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(in thousands)
|
||||||
|
Revenue
|
|
|
|
||||
|
Subscription and support
|
$
|
39,540
|
|
|
$
|
33,585
|
|
|
Professional services
|
12,364
|
|
|
10,966
|
|
||
|
Total revenue
|
51,904
|
|
|
44,551
|
|
||
|
Cost of revenue
|
|
|
|
||||
|
Subscription and support
(1)
|
7,637
|
|
|
6,918
|
|
||
|
Professional services
(1)
|
6,581
|
|
|
6,188
|
|
||
|
Total cost of revenue
|
14,218
|
|
|
13,106
|
|
||
|
Gross profit
|
37,686
|
|
|
31,445
|
|
||
|
Operating expenses
|
|
|
|
||||
|
Research and development
(1)
|
15,536
|
|
|
14,516
|
|
||
|
Sales and marketing
(1)
|
18,713
|
|
|
20,088
|
|
||
|
General and administrative
(1)
|
9,421
|
|
|
8,953
|
|
||
|
Total operating expenses
|
43,670
|
|
|
43,557
|
|
||
|
Loss from operations
|
(5,984
|
)
|
|
(12,112
|
)
|
||
|
Interest expense
|
(455
|
)
|
|
(490
|
)
|
||
|
Other income, net
|
612
|
|
|
576
|
|
||
|
Loss before provision for income taxes
|
(5,827
|
)
|
|
(12,026
|
)
|
||
|
Provision for income taxes
|
9
|
|
|
19
|
|
||
|
Net loss
|
$
|
(5,836
|
)
|
|
$
|
(12,045
|
)
|
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(in thousands)
|
||||||
|
Cost of revenue
|
|
|
|
||||
|
Subscription and support
|
$
|
140
|
|
|
$
|
118
|
|
|
Professional services
|
100
|
|
|
122
|
|
||
|
Operating expenses
|
|
|
|
||||
|
Research and development
|
493
|
|
|
584
|
|
||
|
Sales and marketing
|
659
|
|
|
455
|
|
||
|
General and administrative
|
2,747
|
|
|
2,111
|
|
||
|
Total stock-based compensation expense
|
$
|
4,139
|
|
|
$
|
3,390
|
|
|
|
Three months ended March 31,
|
||||
|
|
2017
|
|
2016
|
||
|
Revenue
|
|
|
|
||
|
Subscription and support
|
76.2
|
%
|
|
75.4
|
%
|
|
Professional services
|
23.8
|
|
|
24.6
|
|
|
Total revenue
|
100.0
|
|
|
100.0
|
|
|
Cost of revenue
|
|
|
|
||
|
Subscription and support
|
14.7
|
|
|
15.5
|
|
|
Professional services
|
12.7
|
|
|
13.9
|
|
|
Total cost of revenue
|
27.4
|
|
|
29.4
|
|
|
Gross profit
|
72.6
|
|
|
70.6
|
|
|
Operating expenses
|
|
|
|
||
|
Research and development
|
29.9
|
|
|
32.6
|
|
|
Sales and marketing
|
36.1
|
|
|
45.1
|
|
|
General and administrative
|
18.2
|
|
|
20.1
|
|
|
Total operating expenses
|
84.2
|
|
|
97.8
|
|
|
Loss from operations
|
(11.6
|
)
|
|
(27.2
|
)
|
|
Interest expense
|
(0.9
|
)
|
|
(1.1
|
)
|
|
Other income, net
|
1.2
|
|
|
1.3
|
|
|
Loss before provision for income taxes
|
(11.3
|
)
|
|
(27.0
|
)
|
|
Benefit for income taxes
|
—
|
|
|
—
|
|
|
Net loss
|
(11.3
|
)%
|
|
(27.0
|
)%
|
|
|
Three months ended March 31,
|
|
|
||||||
|
|
2017
|
|
2016
|
|
% Change
|
||||
|
|
|
|
|
|
|
||||
|
|
(dollars in thousands)
|
||||||||
|
Revenue
|
|
|
|
|
|
||||
|
Subscription and support
|
$
|
39,540
|
|
|
$
|
33,585
|
|
|
17.7%
|
|
Professional services
|
12,364
|
|
|
10,966
|
|
|
12.7%
|
||
|
Total revenue
|
$
|
51,904
|
|
|
$
|
44,551
|
|
|
16.5%
|
|
|
Three months ended March 31,
|
|
|
||||||
|
|
2017
|
|
2016
|
|
% Change
|
||||
|
|
|
|
|
|
|
||||
|
|
(dollars in thousands)
|
||||||||
|
Cost of revenue
|
|
|
|
|
|
||||
|
Subscription and support
|
$
|
7,637
|
|
|
$
|
6,918
|
|
|
10.4%
|
|
Professional services
|
6,581
|
|
|
6,188
|
|
|
6.4%
|
||
|
Total cost of revenue
|
$
|
14,218
|
|
|
$
|
13,106
|
|
|
8.5%
|
|
|
Three months ended March 31,
|
|
|
||||||
|
|
2017
|
|
2016
|
|
% Change
|
||||
|
|
|
|
|
|
|
||||
|
|
(dollars in thousands)
|
||||||||
|
Operating expenses
|
|
|
|
|
|
||||
|
Research and development
|
$
|
15,536
|
|
|
$
|
14,516
|
|
|
7.0%
|
|
Sales and marketing
|
18,713
|
|
|
20,088
|
|
|
(6.8)%
|
||
|
General and administrative
|
9,421
|
|
|
8,953
|
|
|
5.2%
|
||
|
Total operating expenses
|
$
|
43,670
|
|
|
$
|
43,557
|
|
|
0.3%
|
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(dollars in thousands)
|
||||||
|
Interest expense
|
$
|
(455
|
)
|
|
$
|
(490
|
)
|
|
Other income, net
|
612
|
|
|
576
|
|
||
|
|
Three months ended March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(in thousands)
|
||||||
|
Cash flow provided by (used in) operating activities
|
$
|
2,580
|
|
|
$
|
(19,078
|
)
|
|
Cash flow (used in) provided by investing activities
|
(1,242
|
)
|
|
4,326
|
|
||
|
Cash flow used in financing activities
|
(427
|
)
|
|
(726
|
)
|
||
|
Net increase (decrease) in cash and cash equivalents, net of impact of exchange rates
|
$
|
923
|
|
|
$
|
(15,524
|
)
|
|
Date
|
|
Total Number of Shares Purchased
(1)
|
|
Average Price Paid Per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Program
|
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under Program
|
|||||
|
January 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
February 2017
|
|
72,871
|
|
|
$
|
12.85
|
|
|
—
|
|
|
—
|
|
|
March 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
72,871
|
|
|
$
|
12.85
|
|
|
—
|
|
|
—
|
|
|
WORKIVA INC.
|
|
|
|
|
|
By:
|
/s/ Matthew M. Rizai, Ph.D.
|
|
Name:
|
Matthew M. Rizai, Ph.D.
|
|
Title:
|
Chairman and Chief Executive Officer
|
|
|
|
|
By:
|
/s/ J. Stuart Miller
|
|
Name:
|
J. Stuart Miller
|
|
Title:
|
Executive Vice President, Treasurer and Chief Financial Officer
|
|
|
|
|
By:
|
/s/ Jill Klindt
|
|
Name:
|
Jill Klindt
|
|
Title:
|
Senior Vice President and Chief Accounting Officer
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
31.1
|
|
Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2
|
|
Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.1
|
|
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.2
|
|
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|